A detailed history of Morgan Stanley transactions in Natera, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,235,494 shares of NTRA stock, worth $132 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,235,494
Previous 1,299,600 4.93%
Holding current value
$132 Million
Previous $81.4 Million 38.81%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$59.21 - $92.9 $3.8 Million - $5.96 Million
-64,106 Reduced 4.93%
1,235,494 $113 Million
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $4.04 Million - $6.75 Million
107,721 Added 9.04%
1,299,600 $81.4 Million
Q3 2023

Nov 15, 2023

BUY
$43.4 - $62.52 $2.42 Million - $3.48 Million
55,700 Added 4.9%
1,191,879 $52.7 Million
Q2 2023

Aug 14, 2023

SELL
$47.08 - $55.16 $5.75 Million - $6.74 Million
-122,100 Reduced 9.7%
1,136,179 $55.3 Million
Q1 2023

May 15, 2023

SELL
$36.57 - $58.29 $962,668 - $1.53 Million
-26,324 Reduced 2.05%
1,258,279 $69.9 Million
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $12.7 Million - $17.8 Million
371,234 Added 40.64%
1,284,603 $51.6 Million
Q3 2022

Nov 14, 2022

SELL
$36.93 - $56.68 $6.31 Million - $9.68 Million
-170,730 Reduced 15.75%
913,369 $40 Million
Q2 2022

Oct 27, 2022

BUY
$28.13 - $44.54 $11.9 Million - $18.8 Million
422,619 Added 63.89%
1,084,099 $38.4 Million
Q2 2022

Aug 15, 2022

BUY
$28.13 - $44.54 $11.9 Million - $18.8 Million
422,619 Added 63.89%
1,084,099 $38.4 Million
Q1 2022

Oct 27, 2022

SELL
$30.32 - $91.33 $12.8 Million - $38.6 Million
-422,619 Reduced 38.98%
661,480 $26.9 Million
Q1 2022

May 13, 2022

BUY
$30.32 - $91.33 $12.8 Million - $38.6 Million
422,260 Added 176.52%
661,480 $26.9 Million
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $3.61 Million - $4.97 Million
-41,798 Reduced 14.87%
239,220 $22.3 Million
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $28.1 Million - $35.5 Million
281,018 New
281,018 $31.3 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.